The Board granted a 10 percent rating for hypocomplementemic urticarial vasculitis (HUV) from June 16, 2022, and service connection for left lower extremity peripheral neuropathy but denied it for the right lower extremity.
The deciding factor: The July 2023 VA examination noted that chronic urticaria has been nearly continuous since the Veteran's separation from active service and required first line treatment (antihistamines) for control, warranting a 10 percent rating under Diagnostic Code 7825. The Board also found evidence of in-service exposure to fuels and fuel additives supporting direct service connection for peripheral neuropathy affecting both lower extremities.
- Claimed conditions
- hypocomplementemic urticarial vasculitis (HUV), left lower extremity peripheral neuropathy, right lower extremity peripheral neuropathy
- How they argued it
- Direct service connection
- Exposure basis
- None
- Rating assigned
- 10%
- Decision date
- December 3, 2025
- Citation
- A25103906
Want to see how appeals like this one tend to go? Appeals like mine
We are not the VA. Veterans’ Rights is an independent resource built for veterans. We are not the U.S. Department of Veterans Affairs, not part of the government, and not endorsed by any government agency.
This is general information, not legal advice. For advice about your own situation, talk to a VA-accredited representative — many help for free.